This open, knowledge-sharing community supports research teams and encourages local studies to address critical gaps in mpox evidence. New data are urgently needed to improve understanding of transmission, disease severity, and duration, which will inform vaccine development, testing, and more effective detection and diagnosis. Social science research is also essential to strengthen public health education, awareness, and case detection, ultimately improving access to care and reducing transmission.

Here you’ll find the newest research updates and resources from across our network, along with trusted information from the WHO and other key partners. Check back often to explore new tools and materials as they become available.



Interim guidance on social and behavioural research for the mpox public health response - March 2025

This interim guidance aims to clarify standards for high-quality, ethical, social and behavioural research to strengthen the public health response to the ongoing mpox PHEIC for community protection. The guidance is particularly relevant to rapid research that aims to inform near-real-time decision-making and action, but is equally applicable to longer-term research that may be critical for informing future outbreak preparedness and response.

Download the guidance document [PDF 3.9mb]



Mpox Testing Strategy - November 2024

This testing strategy for mpox is a guide for stakeholders supporting the mpox response, including Ministries of Health and other Government agencies, national mpox response task-forces, funding and implementing agencies, public health experts, epidemiologists, front-line healthcare service providers, including clinicians, nurses, laboratory professionals, community healthcare workers and others involved in outbreak preparedness and response activities for enhanced community protection.

Download the strategy [PDF 3.33mb]

 

 


Latest Research Updates

Mpox Global Strategic Preparedness and Response Plan | covering the 6 months from Sep 2024 - Feb 2025 Mpox Continental Preparedness and Response Plan for Africa
Strategic framework for enhancing prevention and control of mpox 2024–2027 | Published: May 2024 Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024 

News Coverage on the Mpox Outbreak

Mpox clade Ib and clade IIb outbreak: epidemiological overview
5 June 2025
Current data regarding mpox clade Ib and clade IIb cases within the United Kingdom. Earlier reports spanning the period from June 2022 through January 2025 contain details exclusively on clade IIb cases.

New mpox strain mutating faster than expected, and other top health stories
30 August 2024 - World Economic Forum 
The new mpox strain spreading from the Democratic Republic of Congo (DRC) is mutating faster than expected, particularly in regions lacking the resources for proper tracking, scientists report. This has led to "numerous unknowns" about the virus’s severity and transmission, complicating the global response, experts in Africa, Europe and the United States told Reuters.

Another worldwide alert – mpox is spreading. Here are three steps we can take to head it off
30 August 2024 - The Guardian
Just a little over a year since declaring that Covid-19 was no longer a public health emergency of international concern and that the 2022-23 mpox crisis had subsided, the World Health Organization finds itself warning of another crisis as cases of yet another new strain of the mpox virus spread from the Democratic Republic of the Congo to other countries in Africa and beyond.

WHO urges rapid access to mpox diagnostic tests, invites manufacturers to emergency review
29 August 2024 - World Health Organization
WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL). WHO has been in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in these discussions.

WHO Director-General declares mpox outbreak a public health emergency of international concern
14 August 2024
WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005) (IHR).